Causes and Management of Elevated Triglycerides

Primary Causes

• Familial hypertriglyceridemia is characterized by triglyceride levels of 200-1000 mg/dL, and is not typically associated with coronary heart disease unless metabolic syndrome features are present, according to the American Heart Association 1, 2
• Familial combined hyperlipidemia (FCHL) is a common genetic disorder (1-2% in white populations) with increased production of apolipoprotein B lipoproteins, as reported by the American Heart Association 1, 2
• Lipoprotein lipase deficiency is a rare genetic disorder causing severely elevated triglycerides and increased risk of pancreatitis, as noted by the American Heart Association 1, 2
• Apolipoprotein CII deficiency is a rare genetic cause of severe hypertriglyceridemia, according to the American Heart Association 2
• Apolipoprotein AV deficiency is a genetic disorder affecting triglyceride metabolism, as reported by the American Heart Association 2
• Dysbetalipoproteinemia is a rare autosomal recessive disorder with defective apolipoprotein E, requiring a second "hit" for clinical expression, according to the American Heart Association 1, 2

Secondary Causes

Metabolic and Endocrine Disorders

• Obesity and overweight are major contributors to mild-to-moderate hypertriglyceridemia (2-10 mmol/L or 176-880 mg/dL), as stated by the American Heart Association 3
• Metabolic syndrome is frequently associated with elevated triglycerides, according to the American Academy of Family Physicians 4
• Poorly controlled diabetes mellitus can cause severely elevated triglycerides, as noted by the American Heart Association 2
• Hypothyroidism affects lipid metabolism leading to elevated triglycerides, according to the American Heart Association 2

Lifestyle Factors

• Excessive alcohol intake, particularly when combined with a high saturated-fat diet, can contribute to elevated triglycerides, as reported by the American Heart Association 2
• Physical inactivity contributes to elevated triglycerides, according to the American Academy of Family Physicians 4
• A diet high in refined carbohydrates increases triglyceride production, as stated by the American Heart Association 5

Medications

• Atypical antipsychotics, particularly clozapine and olanzapine, can raise triglycerides, according to the American Heart Association 6
• Beta-blockers, especially atenolol, can increase triglycerides, as noted by the American Heart Association 2
• Bile acid resins can significantly raise triglycerides in predisposed individuals, according to the American Heart Association 2
• Estrogens, particularly oral formulations, can affect lipid metabolism, as reported by the American Heart Association 2
• Protease inhibitors used in HIV treatment can raise triglycerides, according to the American Heart Association 2
• Retinoic acid drugs can affect lipid metabolism, as noted by the American Heart Association 2
• Sirolimus, an immunosuppressant, can raise triglycerides, according to the American Heart Association 2
• Steroids can affect lipid metabolism, as reported by the American Heart Association 2
• Tamoxifen can raise triglycerides, according to the American Heart Association 2
• Thiazide diuretics, commonly prescribed antihypertensives, can increase triglycerides, as noted by the American Heart Association 2

Other Medical Conditions

• Pregnancy, especially in the third trimester, can lead to elevated triglycerides, according to the American Heart Association 2
• Chronic kidney disease affects lipid metabolism, as reported by the American Heart Association 2
• Autoimmune disorders, such as systemic lupus erythematosus, can be associated with lipid abnormalities, according to the American Heart Association 2
• Chronic idiopathic urticaria is associated with lipid abnormalities, as noted by the American Heart Association 2

Classification of Hypertriglyceridemia

• Mild hypertriglyceridemia is defined as 150-199 mg/dL (1.7-2.3 mmol/L), according to the American Academy of Family Physicians 4
• Moderate hypertriglyceridemia is defined as 200-999 mg/dL (2.3-11.3 mmol/L), as stated by the American Academy of Family Physicians 4
• Severe hypertriglyceridemia is defined as 1,000-1,999 mg/dL (11.3-22.6 mmol/L), according to the American Academy of Family Physicians 4
• Very severe hypertriglyceridemia is defined as ≥2,000 mg/dL (≥22.6 mmol/L), as reported by the American Academy of Family Physicians 4

Clinical Implications

• Mild to moderate hypertriglyceridemia (150-999 mg/dL) may increase cardiovascular disease risk, according to the American Academy of Family Physicians 4
• Severe hypertriglyceridemia (≥1,000 mg/dL) significantly increases the risk of acute pancreatitis, as noted by the American Academy of Family Physicians 4
• Very severe hypertriglyceridemia (≥2,000 mg/dL) poses an immediate risk for pancreatitis, according to the American Heart Association 4, 2

Evaluation Approach

• Assess for secondary causes including diet, alcohol intake, medications, and underlying medical conditions, as stated by the American Academy of Family Physicians 4
• Screen for other components of metabolic syndrome (abdominal obesity, hypertension, low HDL-C, elevated fasting glucose), according to the American Heart Association 5
• Consider genetic testing in cases of severe hypertriglyceridemia without obvious secondary causes, especially with family history, as reported by the American Heart Association 1, 2
• Calculate non-HDL cholesterol and remnant cholesterol to better assess cardiovascular risk, according to the American Heart Association 3

Management Considerations

• For medication-induced hypertriglyceridemia, consider alternative agents when possible, as noted by the American Heart Association 2, 6

Identifying and Managing Causes of Elevated Triglycerides

Primary (Genetic) Causes

• Genetic disorders are a major cause of severe hypertriglyceridemia and require specific identification for targeted therapy. The presence of monogenic or polygenic mutations guides management decisions. 7
• Lipoprotein lipase (LPL) deficiency produces familial chylomicronemia syndrome, typically with triglyceride levels exceeding 1,000 mg/dL and a high risk of pancreatitis. 7
• Apolipoprotein CII deficiency is an autosomal‑recessive disorder that impairs activation of LPL, leading to severe hypertriglyceridemia. 7
• Apolipoprotein AV deficiency disrupts triglyceride metabolism by reducing LPL activity. 7
• GPIHBP1 deficiency prevents proper anchoring of LPL to the capillary endothelium, resulting in marked triglyceride elevation. 7
• LMF1 deficiency interferes with maturation of LPL and hepatic lipase, contributing to hypertriglyceridemia. 7
• Familial combined hyperlipidemia (FCHL) affects 1–2 % of white populations, is characterized by increased apolipoprotein B production, and presents with variable combinations of elevated cholesterol, triglycerides, and/or apoB levels. 7
• Dysbetalipoproteinemia (usually apoE2/E2 genotype) causes accumulation of chylomicron and VLDL remnants, with triglycerides and cholesterol elevated to similar extents. 7

Secondary (Acquired) Metabolic and Endocrine Causes

• Uncontrolled insulin‑deficient diabetes markedly raises triglycerides by increasing hepatic VLDL production and reducing LPL activity. 7
• Hypothyroidism lowers LPL activity and hepatic clearance of triglyceride‑rich lipoproteins, contributing to elevation. 7
• Obesity and visceral adiposity generate mild‑to‑moderate triglyceride elevations (approximately 176–880 mg/dL) through increased hepatic VLDL output and reduced fatty‑acid oxidation. 7
• Metabolic syndrome—a cluster of insulin resistance, central obesity, hypertension, low HDL‑C, and elevated triglycerides—significantly raises triglyceride levels. [7][8]
• Pregnancy (third trimester) physiologically raises triglycerides and may precipitate symptomatic hypertriglyceridemia in susceptible individuals. 7

Lifestyle‑Related Contributors

• Excessive alcohol intake (as little as 1 oz daily) raises triglycerides by 5–10 % and impairs chylomicron hydrolysis; the effect is amplified when combined with a high‑saturated‑fat diet. 7
• Physical inactivity is strongly associated with higher triglyceride concentrations. 7
• Diets high in refined carbohydrates and added sugars directly increase hepatic triglyceride synthesis. [7][8]
• High saturated‑fat diets exacerbate hypertriglyceridemia, especially when alcohol is also consumed. 7

Medication‑Induced Hypertriglyceridemia

• Atypical antipsychotics (especially clozapine and olanzapine) can produce severe triglyceride elevations (>500 mg/dL) with a risk of pancreatitis. 7
• Protease inhibitors (ritonavir, lopinavir) markedly increase triglycerides in patients with HIV. 7
• Oral estrogen therapies (contraceptives, post‑menopausal hormone therapy) raise triglycerides more than transdermal preparations. 7
• Beta‑blockers (particularly atenolol) elevate triglycerides; carvedilol is preferred for diabetic patients. 7
• Thiazide diuretics commonly increase triglyceride levels. 7
• Bile‑acid resins should be avoided when triglycerides exceed 200 mg/dL because they can significantly worsen hypertriglyceridemia. 7
• Corticosteroids, immunosuppressants (cyclosporine, sirolimus, tacrolimus), tamoxifen/raloxifene, retinoic‑acid derivatives (isotretinoin, acitretin), interferon, and L‑asparaginase are all associated with triglyceride elevation. 7

Other Medical Conditions

• Chronic kidney disease and nephrotic syndrome impair triglyceride clearance and stimulate hepatic VLDL production. 7
• Chronic liver disease disrupts normal lipid metabolism, contributing to elevated triglycerides. 7
• Autoimmune disorders such as systemic lupus erythematosus with anti‑LPL antibodies can cause autoimmune chylomicronemia. 7
• Chronic idiopathic urticaria has been linked to lipid abnormalities. 7

Clinical Evaluation and Management Recommendations

• Systematically assess for secondary causes (e.g., alcohol use, medications, uncontrolled diabetes, hypothyroidism) before initiating pharmacologic triglyceride‑lowering therapy. 7
• Review all current medications and discontinue or substitute agents known to raise triglycerides whenever feasible. 7
• Screen for metabolic‑syndrome components—abdominal obesity (waist‑to‑hip ratio), hypertension, low HDL‑C, and elevated fasting glucose—to identify modifiable contributors. [7][8]
• Measure apolipoprotein B; values in the upper 10th percentile together with triglycerides ≥133 mg/dL and hyperapoB ≥120 mg/dL suggest familial combined hyperlipidemia. 7
• Determine apoE genotype when dysbetalipoproteinemia is suspected; a VLDL‑C to plasma triglyceride ratio ≥0.3 supports the diagnosis. 7
• Avoid bile‑acid resin therapy in patients whose triglycerides exceed 200 mg/dL, as it can exacerbate hypertriglyceridemia. 7
• Recognize that increased waist‑to‑hip ratio markedly raises apoB production in FCHL, emphasizing the importance of weight‑management interventions. 7